Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CAVIN1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Genetic Services Laboratory University of Chicago United States | 17 | 29 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 57 | 29 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 480 | 254 |
|
Congenital Generalized Lipodystrophy (CGL) Panel PreventionGenetics, part of Exact Sciences United States | 33 | 9 |
|
Congenital Generalized Lipodystrophy (CGL) via the CAVIN1 (PTRF) Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics, part of Exact Sciences United States | 107 | 83 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 185 | 142 |
|
Genetic Services Laboratory University of Chicago United States | 17 | 20 |
|
CGC Genetics Unilabs Portugal | 1 | 1 |
|
Congenital and familial lipodystrophy panel. NGS panel of 11 genes. Genologica Medica Spain | 29 | 11 |
|
Congenital Genaralized Lipodystrophy Type 4 Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
Lipodystrophy, congenital generalized: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 4 | 4 |
|
GENERALIZED CONGENITAL LIPODYSTROPHY WITH MYOPATHY Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.